Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/<i>β</i>-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers

<table>Microphoto of IL-2<sup>50</sup> cells after 18 h coincubation with K-562 (×100). MTT added.</table>

International Scholarly Research Notices

fig4

Figure 4

Figure 4: Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/<i>β</i>-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers 

Figure 4 | Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers 